The Prostate Cancer Intervention Versus Observation Trial (PIVOT)

ONCOLOGY

Volumn 11, Issue 8, 1997, Pages 1133-1139

  Wilt, Timothy J ^a   Brawer, Michael K ^b   Barnhill, Jamie ^c   Barry, Michael ^c   Blumenstein, Brent ^c   Collins, Joseph ^c   Crowley, Arthur ^c   Culkin, Daniel ^c   Fox, Steven ^c   Johnson, Charles ^c   Kaplan, Richard ^c   Moon, Timothy ^c   Scardino, Peter ^c   Thompson, Ian ^c   Weiss, David ^c   Wheeler, Thomas ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CARCINOMA IN SITU; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; MALE; METHODOLOGY; MORTALITY; MULTICENTER STUDY; PROGNOSIS; PROSTATE TUMOR; PROSTATECTOMY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

AGED; CARCINOMA IN SITU; CLINICAL PROTOCOLS; HUMANS; MALE; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 0031203890     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Wasson JH, Cushman CC, Bruskewitz RC, et al: A structured literature review of treatment for localized prostate cancer. Arch Fam Med 2:487-493, 1993.
2. Fleming C, Wasson JH, Albertsen PC, et al for the Prostate Patient Outcomes Research Team: A decision analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA 269:2650-2659, 1993.
3. Adolfsson J, Steineck G, Whitmore WF: Recent results of management of palpable clinically localized prostate cancer. Cancer 72:310-322, 1993.
4. Mold JW, Holtgrave DR, Bisonni RS, et al: The evaluation and treatment of men with asymptomatic prostate nodules in primary care: A decision analysis. J Fam Pract 34:561-568, 1992.
5. Beck JR, Kattan MW, Miles BJ: A critique of the decision analysis for clinically localized prostate cancer. J Urol 152:1894-1899, 1994.
6. Chodak GW, Thisted RA, Gerber GS, et al: Results of conservative management of clinically localized prostate cancer. N Engl J Med 330:242-282, 1994.
7. Lange PH: The next era for prostate cancer: Controlled clinical trials. JAMA 269:95-96, 1993.
8. Middleton RG, Thompson IM, Austenfeld MS, et al: Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer. J Urol 154:2144-2148, 1995.
9. U.S. Preventive Services Task Force: Guide to Clinical Preventive Services, 2nd ed. Baltimore, Williams & Wilkins, 1996.
10. Gerber GS, Thisted RA, Scardino PT, et al: Results of radical prostatectoray in men with clinically localized prostate cancer: Multi-institutional analysis. JAMA 276:615-619, 1996.
11. Parker SL, Tong T, Bolden S, et al: Cancer statistics, 1996. CA Cancer J Clin 46:5-27, 1996.
12. Barry MJ, Fleming C, Coley CM, et al: Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part IV: Estimating the risks and benefits of an early detection program. Urology 46:445-461, 1995.
13. Lu-Yao GL, McLerran D, Wasson J, et al: for the Prostate Patient Outcomes Research Team: An assessment of radical prostatectomy. JAMA 269:2633-2636, 1993.
14. Paulsen DF, Lin GH, Hinshaw W, et al: The Uro-Oncology Group. Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol 128:502-504, 1982.
15. Kaplan ID, Cox RS, Bagshaw MA: Prostate specific antigen after external beam radiotherapy for prostatic cancer: Follow-up. J Urol 149:519-522, 1993
16. Partin AW, Pound CR, Clemens JQ, et al: Serum PSA after anatomic radical prostatectomy: The Johns Hopkins experience after 10 years. Urol Clin North Am 20:713-725, 1993.
17. Lu-Yao GL, Potosky AL, Albertsen PC, et al: Follow-up prostate cancer treatments after radical prostatectomy: A population-based study. J Natl Cancer Inst 88(3-4):166-173, 1996.
18. Catalona WJ, Smith CDS, Ratliff TL, et al: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 270:948-954, 1993.
19. Kramer ES, Brown ML, Prorok PC, et al: Prostate cancer screening: What we know and what we need to know. Ann Intern Med 119:914-923, 1993.
20. Cantor SB, Spann SJ, Volk RJ, et al: Prostate cancer screening: A decision analysis. J Fam Pract 41:33-41, 1995.
21. Krahn MD, Mahoney JE, Eckman MH, et al: Screening for prostate cancer: A decision analytic view. JAMA 272:773-780, 1994.
22. Fowler FJ, Barry MJ, Lu-Yao G, et al: Patient-reported complications and follow-up treatment following radical prostatectomy: The National Medicare Experience (1988-1990). Urology 42:622-629, 1993.
23. Murphy GP, Mettlin C, Menck H, et al: National patterns of prostate cancer treatment by radical prostatectomy: Results of a survey by the American College of Surgeons Commission on cancer. J Urol 152:1817-1819, 1994.
24. Mazur DJ, Hickam DH: Patient preferences: Survival vs quality-life considerations. J Gen Intern Med 8:374-377, 1993.
25. Litwin MS, Hays RD, Fink A, et al: Quality of life outcomes in men treated for localized prostate cancer. JAMA 273:129-135, 1995.
26. Wilt TJ, Brawer MK: The Prostate Cancer Intervention Versus Observation Trial: A randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer. J Urol 152:1910-1914, 1994.
27. Albertson PC, Fryback DG, Storer BE, et al: The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol 156:127-132, 1996.
28. Selly S, Donovan J, Faulkner A, et al: Diagnosis and Management and Screening of Early Localised Prostate Cancer: A Systematic Review. Health Care Evaluation Unit, University of Bristol, Department of Social Medicine, 1996.